<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0120-3347</journal-id>
<journal-title><![CDATA[Colombian Journal of Anestesiology]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. colomb. anestesiol.]]></abbrev-journal-title>
<issn>0120-3347</issn>
<publisher>
<publisher-name><![CDATA[SCARE-Sociedad Colombiana de Anestesiología y Reanimación]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0120-33472025000200007</article-id>
<article-id pub-id-type="doi">10.5554/22562087.e1137</article-id>
<title-group>
<article-title xml:lang="en"><![CDATA[Semaglutide and delayed gastric emptying: case report and analysis of anesthetic implications]]></article-title>
<article-title xml:lang="es"><![CDATA[Semaglutida y retraso en el vaciamiento gástrico. Reporte de caso y análisis de las implicaciones anestésicas]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Fortis-Olmedo]]></surname>
<given-names><![CDATA[Luis Leobardo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Serna-Muñoz]]></surname>
<given-names><![CDATA[Ricardo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Cruz-V¡llaseñor]]></surname>
<given-names><![CDATA[Jesús Adán]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Achar-Farca]]></surname>
<given-names><![CDATA[Tanya]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Calva-Ruíz]]></surname>
<given-names><![CDATA[Diana Stephanie]]></given-names>
</name>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Centro Médico ABC Anesthesiology Service ]]></institution>
<addr-line><![CDATA[Mexico City ]]></addr-line>
<country>Mexico</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>06</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>06</month>
<year>2025</year>
</pub-date>
<volume>53</volume>
<numero>2</numero>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_arttext&amp;pid=S0120-33472025000200007&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_abstract&amp;pid=S0120-33472025000200007&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_pdf&amp;pid=S0120-33472025000200007&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract Prescriptions and use of glucagon-like peptide-1 receptor agonists (GLP-1) are dramatically increasing as indications expand, from treating diabetes mellitus to weight loss in obese individuals. One of the effects of GLP-i receptor agonists is delayed gastric emptying, which perioperatively may be a reason for concern because of the potential increased risk of aspiration during anesthetic induction and emergence. This study discusses the case of a patient on weekly semaglutide treatment scheduled for elective surgery, with 12 hours of preoperative fasting. Gastric ultrasound (US) showed a full stomach with images suggestive of solid and liquid food content. The surgical procedure was suspended due to high risk of bronchoaspiration and rescheduled after three half-lives of semaglutide. Current evidence-based recommendations for perioperative care of patients on GLP-1 receptor agonists are discussed, reviewing the pharmacokinetic and pharmacodynamic considerations of semaglutide and published case reports to integrate the best care strategy for patients scheduled for elective surgery on GLP-1 analogs.]]></p></abstract>
<abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen Las prescripciones y el uso de agonistas del receptor del péptido similar al glucagón-1 (GLP-1) están aumentando dramáticamente, a medida que aumentan las indicaciones; desde el tratamiento de la diabetes mellitus hasta la pérdida de peso en personas con obesidad. Uno de los efectos de los agonistas del receptor de GLP-1 es retrasar el vaciamiento gástrico. En el contexto perioperatorio, este efecto farmacológico podría ser preocupante, ya que podría incrementar el riesgo de aspiración en la inducción y emersión anestésicas. Presentamos el caso de una paciente programada para cirugía electiva en tratamiento con semaglutida semanal con ayuno preoperatorio de 12 horas. Se realiza ultrasonido (USG) gástrico en el que se evidencia el estómago lleno, con imágenes sugestivas de contenido alimenticio de sólidos y líquidos. Se decide suspender el procedimiento quirúrgico por alto riesgo de broncoaspiración y reprogramarlo al paso de tres vidas medias de la semaglutida. Se discuten las actuales recomendaciones basadas en evidencia para la atención perioperatoria de pacientes en tratamiento con agonistas del receptor de GLP-1, se revisan las consideraciones farmacocinéticas y farmacodinámicas del semaglutida y reportes de caso publicados con el fin de integrar la mejor estrategia de atención de pacientes programados para cirugía electiva en tratamiento con análogos de GLP-1.]]></p></abstract>
<kwd-group>
<kwd lng="en"><![CDATA[Semaglutide]]></kwd>
<kwd lng="en"><![CDATA[GLP-1 receptor agonist]]></kwd>
<kwd lng="en"><![CDATA[Preoperative fasting]]></kwd>
<kwd lng="en"><![CDATA[Regurgitation]]></kwd>
<kwd lng="en"><![CDATA[Anesthesia]]></kwd>
<kwd lng="en"><![CDATA[Anesthesiology]]></kwd>
<kwd lng="es"><![CDATA[Semaglutida]]></kwd>
<kwd lng="es"><![CDATA[Análogos de GLP-1]]></kwd>
<kwd lng="es"><![CDATA[Ayuno preoperatorio]]></kwd>
<kwd lng="es"><![CDATA[Regurgitación]]></kwd>
<kwd lng="es"><![CDATA[Anestesia]]></kwd>
<kwd lng="es"><![CDATA[Anestesiología]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jensterle]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Rizzo]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Haluzík]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Jane&#382;]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Efficacy of GLP-1 RA Approved for weight management in patients with or without diabetes: A narrative review]]></article-title>
<source><![CDATA[Adv Ther]]></source>
<year>2022</year>
<volume>39</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>2452-67</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<collab>American Diabetes Association Professional Practice Committee</collab>
<article-title xml:lang=""><![CDATA[Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2024]]></article-title>
<source><![CDATA[Diabetes Care]]></source>
<year>2024</year>
<volume>47</volume>
<page-range>S158-78</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Crowley]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Scanaill]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Hermanides]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Buggy]]></surname>
<given-names><![CDATA[DJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Current practice in the perioperative management of patients with diabetes mellitus: a narrative review]]></article-title>
<source><![CDATA[Br J Anaesth]]></source>
<year>2023</year>
<volume>131</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>242-52</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Helmstädter]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Keppeler]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Küster]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Münzel]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Daiber]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Steven]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Glucagon-like peptide-1 (GLP-1) receptor agonists and their cardiovascular benefits-The role of the GLP-1 receptor]]></article-title>
<source><![CDATA[British J Pharmacology]]></source>
<year>2021</year>
<volume>179</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>659-76</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lincoff]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
<name>
<surname><![CDATA[Brown-Frandsen]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Colhoun]]></surname>
<given-names><![CDATA[HM]]></given-names>
</name>
<name>
<surname><![CDATA[Deanfield]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Emerson]]></surname>
<given-names><![CDATA[SS]]></given-names>
</name>
<name>
<surname><![CDATA[Esbjerg]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Semaglutide and cardiovascular outcomes in obesity without diabetes]]></article-title>
<source><![CDATA[N Engl J Med]]></source>
<year>2023</year>
<volume>389</volume>
<numero>24</numero>
<issue>24</issue>
<page-range>2221-32</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hall]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Isaacs]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Clements]]></surname>
<given-names><![CDATA[JN]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pharmacokinetics and clinical implications of semaglutide: A new glucagon-like peptide (GLP)-1 receptor agonist]]></article-title>
<source><![CDATA[Clin Pharmacokinet]]></source>
<year>2018</year>
<volume>57</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>1529-38</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gulak]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Murphy]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Regurgitation under anesthesia in a fasted patient prescribed semaglutide for weight loss: a case report]]></article-title>
<source><![CDATA[Can J Anaesth]]></source>
<year>2023</year>
<volume>70</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>1397-400</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Klein]]></surname>
<given-names><![CDATA[SR]]></given-names>
</name>
<name>
<surname><![CDATA[Hobai]]></surname>
<given-names><![CDATA[IA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Semaglutide, delayed gastric emptying, and intraoperative pulmonary aspiration: a case report]]></article-title>
<source><![CDATA[Can J Anaesth]]></source>
<year>2023</year>
<volume>70</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>1394-6</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ushakumari]]></surname>
<given-names><![CDATA[DS]]></given-names>
</name>
<name>
<surname><![CDATA[Sladen]]></surname>
<given-names><![CDATA[RN]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[ASA consensus-based guidance on preoperative management of patients on glucagon-like peptide-1 receptor agonist]]></article-title>
<source><![CDATA[Anesthesiology]]></source>
<year>2024</year>
<volume>140</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>346-8</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Milder]]></surname>
<given-names><![CDATA[DA]]></given-names>
</name>
<name>
<surname><![CDATA[Milder]]></surname>
<given-names><![CDATA[TY]]></given-names>
</name>
<name>
<surname><![CDATA[Liang]]></surname>
<given-names><![CDATA[SS]]></given-names>
</name>
<name>
<surname><![CDATA[Kam]]></surname>
<given-names><![CDATA[PCA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Glucagon-like peptide-1 receptor agonists: a narrative review of clinical pharmacology and implications for peri-operative practice]]></article-title>
<source><![CDATA[Anaesthesia]]></source>
<year>2024</year>
<volume>79</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>735-47</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Willard]]></surname>
<given-names><![CDATA[FS]]></given-names>
</name>
<name>
<surname><![CDATA[Sloop]]></surname>
<given-names><![CDATA[KW]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Physiology and emerging biochemistry of the glucagon-like peptide-1 receptor]]></article-title>
<source><![CDATA[Exp Diabetes Res]]></source>
<year>2012</year>
<page-range>470851</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jones]]></surname>
<given-names><![CDATA[PM]]></given-names>
</name>
<name>
<surname><![CDATA[Hobai]]></surname>
<given-names><![CDATA[IA]]></given-names>
</name>
<name>
<surname><![CDATA[Murphy]]></surname>
<given-names><![CDATA[PM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Anesthesia and glucagon-like peptide-1 receptor agonists: proceed with caution!]]></article-title>
<source><![CDATA[Can J Anaesth]]></source>
<year>2023</year>
<volume>70</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>1281-6</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sherwin]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Hamburger]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Katz]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Jr. S]]></surname>
<given-names><![CDATA[DeMaria]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Influence of semaglutide use on the presence of residual gastric solids on gastric ultrasound: a prospective observational study in volunteers without obesity recently started on semaglutide]]></article-title>
<source><![CDATA[Can J Anaesth]]></source>
<year>2023</year>
<volume>70</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>1300-6</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Joshi]]></surname>
<given-names><![CDATA[GP]]></given-names>
</name>
<name>
<surname><![CDATA[Abdelmalak]]></surname>
<given-names><![CDATA[BB]]></given-names>
</name>
<name>
<surname><![CDATA[Weigel]]></surname>
<given-names><![CDATA[WA]]></given-names>
</name>
<name>
<surname><![CDATA[Harbell]]></surname>
<given-names><![CDATA[MW]]></given-names>
</name>
<name>
<surname><![CDATA[Kuo]]></surname>
<given-names><![CDATA[CI]]></given-names>
</name>
<name>
<surname><![CDATA[Soriano]]></surname>
<given-names><![CDATA[SG]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[2023 American Society of Anesthesiologists Practice Guidelines for Preoperative Fasting: Carbohydrate-containing Clear Liquids with or without Protein, Chewing Gum, and Pediatric Fasting Duration - A Modular Update of the 2017 American Society of Anesthesiologists Practice Guidelines for Preoperative Fasting]]></article-title>
<source><![CDATA[Anesthesiology]]></source>
<year>2023</year>
<volume>138</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>132-51</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Joshi]]></surname>
<given-names><![CDATA[GP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Anesthetic considerations in adult patients on Glucagon-Like Peptide-1 receptor agonists: gastrointestinal focus]]></article-title>
<source><![CDATA[Anesth Analg]]></source>
<year>2024</year>
<volume>138</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>216-20</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Perlas]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Arzola]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Van de Putte]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Point-ofcare gastric ultrasound and aspiration risk assessment: a narrative review]]></article-title>
<source><![CDATA[Can J Anaesth]]></source>
<year>2018</year>
<volume>65</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>437-48</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Apfelbaum]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
<name>
<surname><![CDATA[Hagberg]]></surname>
<given-names><![CDATA[CA]]></given-names>
</name>
<name>
<surname><![CDATA[Connis]]></surname>
<given-names><![CDATA[RT]]></given-names>
</name>
<name>
<surname><![CDATA[Abdelmalak]]></surname>
<given-names><![CDATA[BB]]></given-names>
</name>
<name>
<surname><![CDATA[Agarkar]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Dutton]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[2022 American Society of Anesthesiologists practice guidelines for management of the difficult airway]]></article-title>
<source><![CDATA[Anesthesiology]]></source>
<year>2022</year>
<volume>136</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>31-81</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
